Next Article in Journal
Insights into the Mechanism of Enhanced Dissolution in Solid Crystalline Formulations
Next Article in Special Issue
Photodynamic Therapy for Atherosclerosis: Past, Present, and Future
Previous Article in Journal
l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(4), 507; https://doi.org/10.3390/pharmaceutics16040507
Action Date Notes Link
article pdf uploaded. 7 April 2024 10:43 CEST Version of Record https://www.mdpi.com/1999-4923/16/4/507/pdf-vor
article supplementary file uploaded. 7 April 2024 10:43 CEST - https://www.mdpi.com/1999-4923/16/4/507#supplementary
article xml file uploaded 9 April 2024 06:57 CEST Original file -
article xml uploaded. 9 April 2024 06:57 CEST Update https://www.mdpi.com/1999-4923/16/4/507/xml
article pdf uploaded. 9 April 2024 06:57 CEST Updated version of record https://www.mdpi.com/1999-4923/16/4/507/pdf
article html file updated 9 April 2024 06:59 CEST Original file https://www.mdpi.com/1999-4923/16/4/507/html
Back to TopTop